{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:03Z","timestamp":1761100983256},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2351,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.bbmt.2008.08.010","type":"journal-article","created":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T09:00:59Z","timestamp":1224320459000},"page":"1245-1252","source":"Crossref","is-referenced-by-count":38,"title":["Comparable Outcome of Alternative Donor and Matched Sibling Donor Hematopoietic Stem Cell Transplant for Children with Acute Lymphoblastic Leukemia in First or Second Remission Using Alemtuzumab in a Myeloablative Conditioning Regimen"],"prefix":"10.1016","volume":"14","author":[{"given":"Alana A.","family":"Kennedy-Nasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Doug","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn S.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm K.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Krance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.08.010_bib1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2008.08.010_bib2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01","volume":"97","author":"Silverman","year":"2001","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2008.08.010_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1034\/j.1399-3046.1999.00055.x","article-title":"Acute lymphoblastic leukaemia: whom and when should we transplant?","volume":"3","author":"Eden","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.08.010_bib5","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1182\/blood-2005-12-4942","volume":"107","author":"Eapen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.010_bib6","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood.V99.9.3151","article-title":"Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission","volume":"99","author":"Bunin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.010_bib7","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/sj.leu.2402690","article-title":"Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors","volume":"16","author":"Locatelli","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.08.010_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2141.2002.03282.x","article-title":"Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants","volume":"116","author":"Al-Kasim","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.08.010_bib9","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1182\/blood.V92.12.4581","article-title":"Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection","volume":"92","author":"Hale","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.010_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bmt.1702477","article-title":"CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells","volume":"26","author":"Hale","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bmt.1704975","article-title":"CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors","volume":"35","author":"Popat","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbmt.2007.01.076","article-title":"The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants","volume":"13","author":"Shah","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.cgt.7700664","article-title":"A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells","volume":"11","author":"Wagner","year":"2004","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.bbmt.2008.08.010_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.bmt.1705121","article-title":"Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab","volume":"36","author":"Lamba","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1705164","article-title":"Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)","volume":"36","author":"Myers","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.010_bib17","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2008.08.010_bib18","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.V99.6.2002","article-title":"Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children","volume":"99","author":"Woolfrey","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.010_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bmt.1705853","article-title":"Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations","volume":"40","author":"Gassas","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bbmt.2006.07.011","article-title":"Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia","volume":"12","author":"Kennedy-Nasser","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib21","first-page":"1559","article-title":"Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab","volume":"91","author":"von dem Borne","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2008.08.010_bib22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.exphem.2005.05.009","article-title":"Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed","volume":"33","author":"Dodero","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2008.08.010_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2007.02.011","article-title":"Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab","volume":"13","author":"Das-Gupta","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib24","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1158\/1078-0432.CCR-06-1275","article-title":"Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)","volume":"12","author":"Rodig","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2008.08.010_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","article-title":"High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT","volume":"108","author":"Rezvani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.010_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/14653240510018145","article-title":"Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation","volume":"7","author":"Cohen","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2008.08.010_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1600-6143.2007.02134.x","article-title":"CD4(+)CD25(+)FOXP3(+) regulatory T cells increase de novo in kidney transplant patients after immunodepletion with campath-1H","volume":"8","author":"Bloom","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2008.08.010_bib28","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood.V94.7.2236.419k04_2236_2246","article-title":"Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome","volume":"94","author":"Green","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.010_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108003819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108003819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:30:57Z","timestamp":1589027457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108003819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1083879108003819"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.08.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}